What's new in PMS?

Article

PMS has been a legitimate diagnosis for several decades, but there are no FDA-approved therapies for it. Off-label use of medications that are FDA-approved for PMDD is common in clinical practice. For patients taking daily SSRIs for anxiety or mood symptoms, premenstrual dose adjustment offers a novel management strategy.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe Now!
Recent Videos
Unveiling gender disparities in medicine | Image Credit: findcare.ahn.org.
John Stanley, MD
Related Content
Guiding ob-gyns back to evidence-based care | Image Credit: © Iryna - stock.adobe.com.

Guiding ob-gyns back to evidence-based care

Brian K. Iriye, MD;James D. Keller, MD, MHSA
May 23rd 2025
Article

A thoughtful approach to behavioral change.

Read More

Pap Talk presented by Contemporary OB/GYN

S2E2: Overcoming Racism and Unconscious Bias in OB/GYN

Contemporary OB/GYN Staff
August 19th 2020
Podcast

Senior Editor Angie DeRosa and Associate Editor Lindsey Carr sat down with Drs. Vanessa Rogers and Shawna Nesbitt to discuss racism and unconscious bias in ob/gyn practice.

Listen

Anger hurts your team’s performance and health, and yours too | Image Credit: © tuaindeed - © tuaindeed - stock.adobe.com.

Anger hurts your team’s performance and health, and yours too

James D. Keller, MD, MHSA;Brian K. Iriye, MD
October 17th 2024
Article

Anger in health care affects both patients and professionals with rising violence and negative health outcomes, but understanding its triggers and applying de-escalation techniques can help manage this pervasive issue.

Read More

Do you know you are being scored?

Do you know you are being scored?

James D. Keller, MD, MHSA;Brian K. Iriye, MD
August 8th 2024
Article

Read More

Study finds high rates of harassment in OB-GYN | Image Credit: © Vitalii Vodolazskyi - © Vitalii Vodolazskyi - stock.adobe.com.

Study finds high rates of harassment in OB-GYN

Celeste Krewson, Assistant Editor
May 21st 2024
Article

A new study highlights significant levels of harassment in obstetrics and gynecology, emphasizing the urgent need for effective interventions.

Read More

Survey: State abortion access impacted OB/GYN residency applications

Survey: State abortion access impacted OB/GYN residency applications

Kevin Kunzmann
May 19th 2024
Article

National survey data presented at ACOG 2024 shows many medical students applying for OB/GYN residencies prioritized states with abortion access.

Read More

© 2025 MJH Life Sciences

All rights reserved.